IL17A and systemic lupus erythematosus: The increased percentage of human IL-17+ Tfh cells was detected in the spleens of NSG mice (8 weeks old) engrafted with PBMCs (1×107cells/mouse) from patients with active lupus, while this process could be halted by the knockdown of RORγ in human CD4+ T cells (23).